Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Doubling epirubicin dose intensity (100 mg/m2 versus 50 mg/m2) in the FEC regimen significantly increases response rates. An international randomised phase III study in metastatic breast cancer
PaperCitations, authors & open-access status
Doubling epirubicin dose intensity (100 mg/m2 versus 50 mg/m2) in the FEC regimen significantly increases response rates. An international randomised phase III study in metastatic breast cancer is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 79 citations, 1997 year and bronze oa status.
79
Citations
1997
Year
bronze
OA Status